Multiparametric Assessment of Bone Response in mCRPC Patients Treated With Cabozantinib

NCT05265988 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Alfredo Berruti